Greater Cannabis Company (GCAN) Interest & Investment Income (2018 - 2025)
Greater Cannabis Company (GCAN) recorded quarterly Interest & Investment Income of $1313.0 in Q3 2025, up 122.94% quarter-over-quarter from -$5723.0 in Q4 2024, and up 122.95% on a YoY basis from $588.93 in Q3 2024.
Greater Cannabis Company (GCAN) Interest & Investment Income (2018 - 2025) Analysis & Trends
Greater Cannabis Company's Interest & Investment Income history runs 4 years deep, the most recent figure standing at $1313.0 for Q3 2025.
- In Q3 2025, Interest & Investment Income rose 122.95% year-over-year to $1313.0; the TTM figure through Dec 2025 stood at -$10132.0 (up 34.28% YoY), while the FY2025 annual figure was -$1627.0, up 92.85% from the prior year.
- Interest & Investment Income was $1313.0 for Q3 2025 at Greater Cannabis Company, up from -$5723.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1313.0 in Q3 2025 to a low of -$5723.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Greater Cannabis Company | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,313.00 |
| Dec 31, 2024 | -5,723.00 |
| Sep 30, 2024 | -5,722.00 |
| Sep 30, 2019 | -3,972.00 |
| Sep 30, 2018 | -14,515.00 |
| Mar 31, 2018 | 5,903.00 |